Reduced expression of ChK2 has been reported in breast cancer with and without mutations (Sullivan et al, 2002; Kilpivaara et al, 2005), with similar correlations to tumour characteristics as in the present study, but with no relationship to survival. Here, CHEK2 is linked to neoplasm.